Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) shares passed below its fifty day moving av...
Seres Therapeutics, Inc. (NASDAQ:MCRB - Get Free Report) saw a large increase in short interest in M...
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has been given a consensus rating of “Reduc...
CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB) (Seres or ...